
A Brave New World: Recruiting Patients for DCTs and Hybrid Trials
During the COVID-19 pandemic, many clinical trials were halted or stopped altogether due to the inability to recruit and screen patients. Much of this was due to a centralized study set up, where patients were required to appear in person for screening and secondary study visit activities. As the pandemic progressed, the need for an alternate approach was high.
Read More